Cite
MLA Citation
V. Ribrag et al.. “MCL‐R2 ELDERLY: A PHASE III STUDY OF THE EUROPEAN MCL NETWORK ASSESSING EFFICACY OF ALTERNATING IMMUNOCHEMOTHERAPY (R‐CHOP / R‐HAD) AND a RITUXIMAB‐LENALIDOMIDE MAINTENANCE.” Hematological oncology, vol. 35, n.d., p. 421. http://access.bl.uk/ark:/81055/vdc_100047476173.0x00002a